Video collection: Read & Publish and Open Access
The Company of Biologists has been committed to Open Access since 2004 and we have a track record of innovation. We were one of the first not-for-profit publishers to launch a cost-neutral Read & Publish Open Access initiative and our hybrid journals were the first in the world to be afforded Transformative Journal status by Plan S.
Our Read & Publish initiative has gone from strength to strength, and corresponding authors at over 650 institutions in 41 countries now benefit from fee-free Open Access publishing in our journals as well as access to the journals and their backfiles.
In this very popular and highly practical 90-minute webinar that we co-hosted with HUBS (Heads of Universities Biosciences) on 23 February 2023, expert speakers from across the scholarly community demonstrated and discussed ways in which researchers can increase the visibility and impact of their research and raise their profile internationally.
Has the success of The Company of Biologists' Read & Publish initiative led to an increase in the research content that has been published immediately Open Access in Development, Journal of Cell Science and Journal of Experimental Biology? Absolutely! Learn more in this short video presented by Claire Moulton (Publisher at The Company of Biologists).
Why is Open Access important? Are Read & Publish agreements supporting the move to OA? Hear what the Editors-in-Chief of Development, Journal of Cell Science and Journal of Experimental Biology say.
What do authors say about APC-free Open Access publishing? Hear six authors talk about their experience of publishing their articles Open Access through our Read & Publish initiative.